Mr. Stanton J. Rowe is CEO of Nidus Biomedical, a medical device incubator in California. Mr. Rowe was the Chief Scientific Officer of Edwards Lifesciences for 15 years and served as its Corporate Vice President of Advanced Technology. Mr. Rowe was a founder, and served as the CEO of Percutaneous Valve Technologies Inc. This company developed the first TAVR device, sold to Edwards in 2004. He serves as a Director of Gradient Denervation, Anuncia Medical, Vivifi Medical, XCure, and the Discovery Science Center.

Mr. Rowe has served numerous Biomedical Engineering Advisory Boards at UCI, UC Davis, Texas A&M, Brown University and Georgia Tech. He holds a Bachelor’s Degree and a DSc (honoris) from the University of Alabama.